Logiscreen

Biolife Solutions Inc

$26.65
Market Cap 1.29B
ROE -0.8%
Gross Margin 63.6%
Debt/Equity 0.0
Current Ratio 7.3
Revenue QoQ 24.7%
EPS QoQ -3.0%
F-Score 4

About

BioLife Solutions, Inc. (BioLife) is a life sciences tools provider. The Company's product offerings include bio-preservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services, and contract aseptic manufacturing fill and finish services. Its HypoThermosol, CryoStor, and generic BloodStor biopreservation media products are marketed to regenerative medicine companies, hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant surgeons, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-441.89
vs median 33.61
P/B
3.52
vs median 2.16
ROE
-0.01
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics